Generic drugs likely to benefit from possible drug shortage

Published: 2007-06-20 06:58:00

Updated: 2007-06-20 06:58:00

Pharmaceutical sources said the sales of generic drugs and bioequivalence-proven medicines will be expanded as the dispute between Zuellig Pharma Korea and its associate wholesalers has dragged on.

Korean generic drug manufacturers are expected to boost their sales on hopes that doctors and ph...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK